Demo and Trial Periods: What to Test Before Signing

A vendor-run demonstration is a sales event — your trial period is the only chance to find out how a device performs in your environment before money changes hands.

Why this matters

Picture a mid-sized community hospital that ran a two-hour vendor demonstration of a new patient monitoring platform in a conference room. The display was clean, the alarm logic was explained confidently, and the sales team answered every question. The procurement committee signed the contract, and 40 units were installed across two med-surg floors. Within three months, the biomed team had logged 27 service calls — most of them related to wireless connectivity dropouts that never surfaced in the demo environment's hardwired setup. The EHR integration required a middleware patch that took four months to negotiate.

That scenario is common enough that ECRI Institute's Health Devices program has consistently flagged inadequate pre-purchase evaluation as a contributing factor in technology management failures (S1). The problem is rarely vendor dishonesty. A polished demonstration is simply designed to show equipment at its best, operated by someone who knows every quirk of that specific unit. Your environment has network congestion, humidity swings, staff with varying training levels, and patients who don't hold still. A 30-minute conference room walkthrough reveals almost none of that.

A structured trial — typically 30 to 90 days depending on device complexity — exists to expose the gap between demo conditions and operational reality. Done right, it also gives clinical end-users genuine input before commitment, which is a prerequisite for adoption. Done poorly, it's just a longer demo with no measurable output and no leverage at the negotiating table.

The decisions that shape the outcome

How long to run the trial

Duration should match the complexity and clinical risk of the device. For high-frequency, lower-acuity equipment — infusion pumps, pulse oximeters, examination lights — 30 days is often sufficient if you achieve representative volume. For capital equipment such as imaging systems, laboratory analyzers, or surgical platforms, 60 to 90 days is more defensible, because failure modes that occur probabilistically rather than every cycle need time to surface. ANSI/AAMI EQ56 frames equipment management around clinical risk stratification (S2); that same logic applies to evaluation depth.

Who participates

Biomed engineers need to be present during installation — not just called in when something breaks. They should document service access points, verify electrical safety compliance with IEC 60601-1 for the intended environment, and confirm that the trial unit's firmware version matches what will ship in a production order. Vendors have been known to trial late-stage prototype configurations. Clinical end-users — nurses, technicians, radiographers — need unscripted operating time, not a supervised walkthrough with a vendor application specialist standing by to catch every stumble.

What you actually measure

A trial without defined metrics produces a subjective impression, not a procurement decision. Before the trial starts, agree on at least three to five quantitative criteria: alarm false-positive rate, time-to-result or cycle time, observed downtime events, consumable consumption rate, and response time on service inquiries. If a vendor claims an MTBF exceeding 20,000 hours and your 60-day trial surfaces two unplanned failures on a single unit, that is documented grounds to renegotiate or exit.

Regulatory and integration verification

Before the trial unit enters a patient care area, confirm its 510(k) clearance number via the FDA's premarket notification database (S3) and verify it matches the intended purchase configuration — not a cleared predecessor model with a different hardware revision. If the device connects to your network or EHR, cybersecurity assessment cannot be deferred until post-deployment. FDA guidance on device cybersecurity in premarket submissions sets expectations that your risk management process should be evaluating during the trial itself, not patching in afterward (S4).

Common mistakes

The most pervasive mistake is letting the vendor control the trial environment throughout. A manufacturer application specialist on-site every day is useful for training in the first week, but if that person is also handling every operational hiccup, you are not seeing how the device behaves when your team is on its own at 2 a.m. on a weekend. Build a formal vendor-free window — at least two weeks — into any trial plan, and log every friction point independently during that period.

A second mistake is evaluating the device while ignoring the service ecosystem around it. You can test a ventilator's tidal volume accuracy to four decimal places, but if the nearest field service engineer is four hours away and the draft SLA contains no guaranteed response window, you have incomplete information. During the trial, submit one or two intentional low-urgency service requests and time the response. Ask for the escalation path in writing. That response time is a better predictor of long-term service experience than any reference call.

A third mistake is excluding bedside clinical staff in favor of administrative efficiency. A department manager may champion a new pump because it reduces reconciliation errors on paper, while the nurses who prime and program it find the interface cognitively disruptive under load. Poor adoption follows, and so do workarounds that introduce new risks. The people pressing buttons at shift change are the intended users; their structured feedback is not optional.

Finally — and this compounds every other mistake — most facilities do not document trials formally. Anecdotal recollections carry no weight if you later need to enforce a warranty clause or dispute a performance guarantee. Assign one person to maintain a contemporaneous trial log: dates, observed issues, service calls, downtime events, and user feedback. That document is also your foundation for post-market surveillance under your equipment management program.

A practical workflow

1. Write pass/fail criteria before the trial begins. Define at least three measurable thresholds — maximum acceptable downtime, alarm false-positive ceiling, or cycle-time target — so the evaluation doesn't default to impression.
2. Verify the trial unit's regulatory and firmware status. Confirm the 510(k) clearance number and that the firmware is production-equivalent, not a development build.
3. Schedule a vendor-free evaluation window. Reserve at least two weeks where staff operate the device independently and log every issue without manufacturer